EN DE

United American Healthcare Corporation (UAHC) Fair Value & Analysis

Real Estate · US · Market cap $2.0M

UA United American Healthcare Corporation logo United American Healthcare Corporation UAHC · US
Price$0.0170
Fair Value$0.0182
Upside+7.1%
Quality70/100
Watch United American Healthcare Corporation for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -36.8% net margin
Low debt · generates free cash flow
Mixed vs. peers (6/12)
Narrow moat 20/100
Evidence: High Range $0.0182 – $0.0198 Share as image

Fair value as of: Jul 31, 2026

From 16 valuation models · updated 10 days ago

Share price −19.0% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price is below even our cautious bear case ($0.0182). The market is more pessimistic than our downside scenario.
  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • The models converge in a tight band ($0.0182 to $0.0198), unusually little disagreement for a valuation.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$0.0980 $0.0069 Fair Value $0.0182 Feb 2020 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.

How to read this chart

60‑month range $0.0069 – $0.0980 · fair‑value band $0.0182 – $0.0198 · the $0.0170 price screens below the $0.0182 fair value. Dashed = 300-day average. As of Jul 31, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

United American Healthcare Corporation (UAHC) currently trades at $0.0170, while our model-based Fair Value estimate is $0.0182, implying the stock looks roughly 7.1% fairly valued today. The Quality Score stands at 70/100 (solid quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, United American Healthcare Corporation generated revenue of $5.8M at a net margin of -36.8%. Revenue grew 23.3% year over year. The stock trades on a trailing P/E of 0.6. Fundamentals as of Jul 31, 2026

Our scenario range runs from $0.0182 (bear case) to $0.0198 (bull case); at $0.0170, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high and 55% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -2% fair-value upside, at 7%, UAHC screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $0.0600 $0.0700 $0.0900 80
Residual Income $0.0100 $0.0100 $0.0400 76
Rev-Margin DCF $0.0600 $0.0900 $0.1200 74
All 16 models by family
DCF Models
FCF DCF $0.0600 $0.0700 $0.0900 38
Owner Earnings $0.0200 $0.0200 $0.0300 31
5Y Revenue Exit $0.0600 $0.0900 $0.1200 39
5Y P/E Exit $0.0400 $0.0600 $0.0700 38
10Y Revenue Exit $0.0600 $0.0700 $0.0900 36
10Y P/E Exit $0.0500 $0.0600 $0.0700 35
Earnings-Based
Graham-Dodd $0.0100 $0.0200 $0.0200 54
Multiples
P/E Multiple $0.0300 $0.0400 $0.0600 63
P/S Multiple $0.0300 $0.0300 $0.0400 58
P/B Multiple $0.0300 $0.0300 $0.0400 55
EV/Revenue $0.0700 $0.1000 $0.1300 43
Asset-Based
NCAV (Graham) $0.0100 $0.0100 50
Growth DCF
Growth DCF $0.0600 $0.0700 $0.0900 80
Rev-Margin DCF $0.0600 $0.0900 $0.1200 74
Economic Profit
Residual Income $0.0100 $0.0100 $0.0400 76
Growth Earnings
Growth-Adj P/E $0.0200 $0.0300 $0.0400 68

Widest divergence: Growth DCF ($0.0700) versus Asset-Based ($0.0100). Highest evidence: Growth DCF (80).

Notify me when UAHC reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $5.8M
Revenue growth (YoY) +23.3%
Net margin -36.8%
Free cash flow $860K FY2023
P/E ratio 0.6
Operating margin 7.8%
More key figures
EPS (TTM) $0.0300
EPS growth (YoY) +418%
Net cash $374K FY2024

Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 70/100

Of which business quality 73 · Market factors (momentum, volatility) 52

Profitability 59
Margins and returns on capital today
Quality Growth 74
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 67
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 60
Price trend over the last 3–12 months (market factor)
52W Momentum 40
Distance to the 52-week high (market factor)
Net Issuance 86
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

United American Healthcare Corporation, through its subsidiaries, provides comprehensive management and consulting services to managed care organizations and other administrative services related to employee welfare and health benefit plans. The company was incorporated in 1983 and is based in Chicago, Illinois.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2013 – FY2024 · reported fiscal years

United American Healthcare Corporation reported revenue of $10.7M in FY2017 versus $6.5M in FY2013, a compound +13.4%/yr. Reported net income was $238K in FY2024.

Growth Quality 60/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2017)
$10.7M
Latest YoY
+20.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.7%
Avg. growth/yr (28Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.0%
Revenue +13.4%/yr
FY13 $6.5M
FY14 $7.9M
FY15 $9.0M
FY16 $8.9M
FY17 $10.7M
Net income
FY20 −$2.6M
FY21 −$4.0K
FY22 −$188K
FY23 $723K
FY24 $238K

Watch UAHC: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "United American Healthcare Corporation Fair Value". https://www.fairvalue-calculator.com/stock/UAHC

Peer Group

Real Estate Services · 520 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 72 · Top 25%
Fair Value upside +18% · Above median
Return on assets 0% · Bottom 25%
Net margin (TTM) -37% · Bottom 25%
Operating margin (TTM) 8% · Below median
Revenue growth 23% · Top 25%
Debt / equity 0.01× · Lower than 75% of peers

Valuation Multiples vs Real Estate Services median · lower = cheaper

P/E (TTM) 0.6× · Cheaper than 75% of peers
P/B 1.76× · Pricier than 75% of peers
P/S (TTM) 0.34× · Cheaper than 75% of peers
P/FCF 2.3× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 57 · sector 37
FUTURE 100 · sector 10
PAST 0 · sector 16
HEALTH 100 · sector 85
DIVIDEND 0 · sector 49

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).

Stock Price Fair Value vs Fair Value
Vingroup Joint Stock Company VIC 223,000 VND 25,731 VND -88%
KE Holdings 2423 HK$44.76 HK$18.03 -60%
Swire Properties Limited 1972 HK$23.90 HK$18.75 -22%
Plaza S.A MALLPLAZA 3,725 CLP 5,571 CLP +50%
SAGAA SAGAA kr 170.00 kr 75.55 -56%
Cencosud Shopping S.A CENCOMALLS 2,324 CLP 2,976 CLP +28%
PT Sarana Menara Nusantara Tbk. owns and TOWR 372.00 IDR 1,208 IDR +225%
PT Metropolitan Kentjana Tbk MKPI 20,975 IDR 19,160 IDR -9%
PT Bangun Kosambi Sukses Tbk, CBDK 3,530 IDR 3,464 IDR -2%
IRSA Inversiones y Representaciones Sociedad Anónima, IRSA 2,495 ARS 3,998 ARS +60%

Compare United American Healthcare Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is United American Healthcare Corporation (UAHC) overvalued or undervalued?
As of Jul 31, 2026, our model estimates a fair value of $0.0182 versus a price of $0.0170, about +7% (fairly valued).
What is the fair value of UAHC?
Our model-based fair value for United American Healthcare Corporation is $0.0182 (as of Jul 31, 2026), built from audited fundamentals. The current price is $0.0170.
What is the quality score of UAHC?
United American Healthcare Corporation has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of United American Healthcare Corporation (UAHC)?
United American Healthcare Corporation reported trailing-twelve-month revenue of about $5.8M (latest available figure, as of Jul 31, 2026).
What is the net profit margin of UAHC?
The net profit margin of United American Healthcare Corporation is about -36.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track United American Healthcare Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.